Investor Presentaiton
Operating Income
Adjusted Operating Income of $7.4 billion, up 8.1%
Amounts in billions, except as noted. Dollar changes may not recalculate due to rounding.
$6.9
Operating Income
$2.7
$6.2
$5.6
Adjusted Operating Income
$7.3
$6.9
$6.4
$6.2
$6.0
$7.4
Q2 FY24
Adjusted operating income' up
8.1% relative to 5.9% growth in
net sales
Net income margin increased
~150bps and Adjusted EBITDA
margin increased ~10bps over
last year
Q3 FY23 and Q4 FY23 negatively
affected by discrete charges of
$3.3B and $0.8B, respectively,
associated with the opioid legal
settlement frameworks, and
business reorganization and
restructurings
Q2 FY23
Q3 FY23
Q4 FY23
Q1 FY24
Q2 FY24
Q2 FY23
Q3 FY23
Q4 FY23
Q1 FY24
Y/Y Change
-6.8%
-53.5%
-5.5%
+17.3%
+6.7%
Y/Y Change
-6.8%
+3.9%
+6.9%
+17.3%
+8.1%
Y/Y Change (cc)' -6.0%
-52.8%
-6.5%
+16.0%
+4.9%
Y/Y Change (cc)' -6.0%
+4.6%
+6.3%
+16.0%
+6.3%
'See additional information at the end of this presentation regarding non-GAAP financial measures.View entire presentation